Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 30,100 shares at $112.47 ($3.4M) on 2014-11-04, disclosed to the SEC on 2014-11-05.
Scheduled sale ($3.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.03 | 17,316 | $1.9M | 57.2% |
| 2 | $112.80 | 2,684 | $303K | 8.9% |
| 3 | $112.47 | 2,300 | $259K | 7.6% |
| 4 | $113.47 | 3,200 | $363K | 10.7% |
| 5 | $114.23 | 4,400 | $503K | 14.8% |
| 6 | $115.45 | 100 |
| $12K |
| 0.3% |
| 7 | $111.86 | 100 | $11K | 0.3% |
| Total | $112.62 avg | 30,100 | $3.4M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |